approximately 46% of the U.S. population aged 12 years and older have tried an illicit drug in their lifetime. 5 In addition, the lifetime prevalence of drug abuse and dependence among U.S. adults is 8 and 3%, respectively. 6 In 2015 alone, it was estimated that more than 33,000 deaths were attributable to illicit drugs. 7 Recently, the United States has experienced the rise of an opioid epidemic; so much so that the White House has declared the opioid crisis a public health emergency.
8 A large part of this problem is the use of opioids for acute or chronic pain by more than 125 million Americans. 7 Additionally, for some medical specialties, such as orthopaedics, the use of opioids is almost a necessity for pain control. 9 In fact, in a recent study by Kaafarani et al, the group found orthopaedics to be one of the highest opioid prescribing services at the Massachusetts General Hospital. 10 Although opioids remain a common medication class for postoperative management, some studies have found that patients with a history of chronic opioid use have worse pain management outcomes following to total hip or total knee arthroplasty (TKA). 11, 12 However, because of the rising number of opioid users, as well as the continuous increase in orthopaedic procedures, the association between drug use and TKA needs to be more clearly identified. Illicit drug use and prescription drug abuse are two independent factors that might have consequences resulting in revision TKA (RTKA). Currently, the effects of drug abuse in RTKA have not been adequately studied. Previous studies that have investigated the effect of drug abuse in total joint arthroplasty have primarily focused on the hip, or have only analyzed small sample sizes.
2,3 Therefore, the purpose of this study was to determine the effects of drug abuse in TKA patients who eventually needed a revision using a large nationwide database. Specifically, we used the Medicare database from 2005 to 2012 to identify RTKA: (1) incidence, (2) causes, and (3) time to RTKA in patients with a history of abusing cocaine, cannabis, opioids, SHA, amphetamines, and/or alcohol. Drug user patient demographics were also correlated with RTKA.
Methods Data Source
A retrospective review of a comprehensive Medicare database within the PearlDiver Supercomputer application (Warsaw, IN) for TKA and RTKA procedure was performed. The PearlDiver database is a publicly available, Health Insurance Portability and Accountability Act compliant national database compiled from a collection of U.S. Medicare records. This database contains current procedural terminology (CPT) and International Classification of Diseases, Ninth Revision (ICD-9) codes from January 1, 2005, to December 31, 2014.
Patient Selection
Patients who underwent primary TKA were identified by CPT 27447 and ICD-9 81.54. RTKA patients were identified with CPT-27486, CPT-27487, ICD-9 00.80-00.84, and ICD-9 81.55. 
Data Analysis
Study end points were annual volume and incidence changes for the above-defined patients undergoing RTKA. These end points were assessed through linear regressions models. Mean values were compared through a one-way analysis of variance (ANOVA) with post hoc evaluations using Bonferroni correction. Chi-square testing was also performed to evaluate distribution of time to revision among groups. Significance was set at an α of 0.05. All tests were performed with SPSS (Version 20, IBM Corporation, Armonk, NY).
Results
Over the 10-year study period, there was a significant increase in the number of primary TKAs performed (p < 0.001), as well as, TKA in cocaine (p ¼ 0.011), cannabis (p < 0.001), opioid (p < 0.001), SHA (p < 0.001), amphetamine (p < 0.001), and alcohol (p < 0.001; ►Fig. 1) users. There was a significant increase in the number of RTKA performed from 2005 to 2014; however, no significant increases in number of RTKA by drug abuse/dependence were observed (►Table 1). Nevertheless, 9% (n ¼ 248,098) of patients in the general population underwent RTKA compared with an average of 12.9% of drug and alcohol abusers/dependent patients required RTKA, which was found to be significant (p < 0.001). Post hoc Bonferroni testing demonstrated that cocaine use was associated with a significantly higher revision rate (15.1%), followed by amphetamines (13.7%) and opioids (12.9%, p < 0.001; ►Table 1).
The mean time to RTKA in the general population was 821 days (standard deviation [SD]: 741 days). Amphetamine users had the fastest mean time to revision (691 days, SD: 679 days); however, there was no significant difference in time to revision across different drug abuse cohorts (ANOVA, p ¼ 0.0978; ►Table 2). At 30-, 90-day, and 6-month postoperative, cocaine had the highest proportion of patients requiring RTKA (7, 12 , and 20%, respectively), and at 1-year alcohol abusers (38%, p < 0.001; ►Table 3). Infection was the most common cause of revision in all drug abuse/dependent cohorts (►Table 4). 
Discussion
Although there are a few prior studies investigating the effects of substance abuse on joint arthroplasty, these studies do not address specific illicit drugs.
1,2,4 Thus, the purpose of this study was to determine the effects of individual illicit drug abuse on RTKA incidence, causes, and time to revision, as well as correlate drug user patient demographics with RTKA using a Medicare patient population database. The results of this study show that illicit drug use, in general, increases the risk for revision and on average, and all illicit drug abuse lead to earlier revision. This study is not without limitations. The PearlDiver database is reliant upon accurate CPT or ICD codes, which creates the potential for a reporting bias. Additionally, we do not have information on the implant used, prosthesis fixation method, patient bone quality, and data regarding which component failed. Furthermore, patient demographics as well as time and amount of drug use could not be determined. Also, we were not able to differentiate illicit opioid abuse versus prescription opioid abuse. Therefore, the opioid abuse patients analyzed in this article encompass all patients with cause for RTKA identified to be opioids based on ICD-9 codes 304.00-02 and 305.50-52 as a single cohort. Nevertheless, this study analyzes more than 2 million TKA cases from a large national patient population database. Additionally, this study investigated the specific drugs abused and the causes of RTKA in subgroups that have not been previously adequately studied in the literature.
Similar to our study, other studies have found analogous results. Dufour et al 13 performed a retrospective study analyzing the prevalence of diagnosed opioid abuse in commercial versus Medicare patient populations. The group found an increased 6-month prevalence of diagnosed opioid patients with a mean age of 56 years (range, 37-78) who underwent TKA after 6 or more weeks of chronic opioid use for pain control and to a matched cohort of nonopioid users. The group found Knee Society scores (KSSs) to be significantly lower in opioid abusers at final follow-up (mean, 3 years; range, 2-7 years). Opioid abusers had a mean KSS of 79 points (range, 45-100 points), while nonopioid patients had a mean of 92 points (range, 59-100 points). Additionally, opioid abusers underwent a significantly higher number of surgical procedures to help resolve unexplained knee stiffness or pain than nonopioid users (11 vs. 0, p < 0.001).
The study also found that chronic opioid use prior to TKA contributed to a 16% revision rate, consistent with the results of our study. Based on the results of ours and the above studies, there is clearly a strong correlation between drug abuse and adverse primary TKA outcomes, potentially resulting in RTKA. Based on these results, therefore, a more targeted approach should be made when managing pain in orthopaedic patients. Specifically, patients and physicians need to keep in mind that it has been well documented in the literature that patients have poorer pain outcomes and are more likely to be opioid/drug dependent postoperatively if treated with opioids preoperatively. 11, 15 Additionally, as noted in this study, certain drugs, such as alcohol, opioids, and cannabis, can put patients at higher risk for TKA complications. Recent literature has suggested the use of nonopioid management techniques, such as intraoperative local infiltration analgesia 16 or peripheral nerve blocks. 17 However, specifically for drug abuse patients, these newer potential treatment options should be coupled with risk stratification, as well as a more holistic and life-style altering approach to pain management.
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Conclusion
The prevalence of drug abuse patients, particularly Medicare patients, is of substantial concern, and will remain a concern until marked changes are made to the way these patients managed. Therefore, studies such as this are critical in identifying specific incidences and prevalences, specific illicit drugs abused, and patient demographics, to target and improve patient care. Although alcohol and opioids are the most abused substances, cocaine abuse holds the highest risk for revision. However, those who abuse cannabis are more likely to need an RTKA sooner than those who use other substances, particularly in the 30-and 90-day postoperative day intervals. Infection remains one of the most common causes of revision post-TKA regardless of the substance abused. The results of this study help highlight the strong correlation between drug abuse and RTKA. Based on these results, therefore, drug abuse patients should therefore be appropriately risk stratified and receive comprehensive postoperative pain management.
